RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Teshome Yehualaeshet to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Teshome Yehualaeshet has written about Xenograft Model Antitumor Assays.
Teshome Yehualaeshet
Connection Strength
0.030
Xenograft Model Antitumor Assays
  1. Fadlalla K, Elgendy R, Gilbreath E, Pondugula SR, Yehualaeshet T, Mansour M, Serbessa T, Manne U, Samuel T. 3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-?B activation. Oncol Rep. 2015 Jul; 34(1):495-503.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support